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ing status, and cancer history, as well as history of heart fail-
ure, myocardial infarction, or stroke. We believe that by
including these characteristics in our model we have ac-
counted for frailty with regard to mortality, and therefore
we have not performed the additional requested sensitivity
analyses.
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Effect of Oral Glucosamine on Pain-Related
Disability in Patients With Chronic Low Back Pain
To the Editor: In their randomized placebo-controlled
trial, Mr Wilkens and colleagues1 studied the effect of
oral glucosamine on pain-related disability in patients
with chronic low back pain (LBP). The authors con-
cluded that, in a representative sample of the LBP popu-
lation presenting in general clinical practice, oral glu-
cosamine did not provide any advantages over placebo
for self-administered functional, pain-related, and
quality-of-life outcome measures.
However, based on the information given in the article,
we find it hard to assess the generalizability of the study find-
ings. The authors described that recruitment occurred via
general practitioners, physiotherapists, chiropractors, and
self-referrals through a newspaper advertisement. It would
be helpful to know the distribution of included partici-
pants among these 4 methods of recruitment. Self-referred
participants had to meet the additional requirement of a re-
cent magnetic resonance imaging (MRI) scan, but it would
be helpful to have more information about the Norwegian
health care system to understand the implications of this
route. A more precise description of the way the investiga-
tors recruited the participants would also result in a clearer
description of the study population.
In our opinion, patients with a new episode of chronic
LBP who report to a general practitioner might well differ
from patients with a long history of LBP seen by a chiro-
practor. If all 4methods of recruitment provided similar num-
bers of participants, we doubt whether the studied popu-
lation is a representative sample of the LBP population
presenting in general clinical practice.
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In Reply: Drs Runhaar and van der Wouden raise interest-
ing points about patient population generalizability in our
clinical trial. In our view, patients included in our studywere
representative of patients seen in general clinical practice.
Recruitmentwas 16.4%by general practitioners, 52.0% from
chiropractors, 12.0% fromphysiotherapists, and 19.6% from
the newspaper advertisement. In Norway, persons with
chronic LBP with or without an acute flare often see differ-
ent types of health care personnel according to their own
preferences. Medical doctors, chiropractors, and physio-
therapists specializing inmanual therapy are licensed to pre-
scribe sick leave; order x-ray tests, computed tomography,
and MRIs; and refer to medical specialists.
Therefore, the difference between patients attending gen-
eral practitioners and patients attending chiropractors or
physiotherapists is probably limited. To our knowledge, there
is no evidence supporting a notion of patient difference based
on health care personnel. Thus, in terms of recruitment, we
consider our group of selected patients generalizable to gen-
eral clinical practice.
We also believe that recruitment fromdifferent health care
personnel strengthens the generalizability of the population,
which is principally a function of the inclusion and exclu-
sion criteria used to include the appropriate patients. Addi-
tionally, regardless of path into the study, the majority of the
patients had visited their primary physicians and 1 or more
physiotherapists or chiropractors recently or in the past.
All patients were required to have had an MRI, not only
the self-referred patients. In Norway, the public health in-
surance agency assumes the cost of the MRI, apart from a
minor out-of-pocket fee of approximately $40.
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